Dehydroepiandrosterone sulfate and beta-cell function: enhanced glucose-induced insulin secretion and altered gene expression in rodent pancreatic beta-cells. 2000

J S Dillon, and G C Yaney, and Y Zhou, and N Voilley, and S Bowen, and S Chipkin, and C R Bliss, and V Schultz, and F C Schuit, and M Prentki, and D J Waxman, and B E Corkey
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, USA. joseph-dillon@uiowa.edu

Administration of dehydroepiandrosterone (DHEA), or its sulfated form (DHEAS), controls hyperglycemia in diabetic rodents without directly altering insulin sensitivity. We show that DHEAS enhanced glucose-stimulated insulin secretion when administered in vivo to rats or in vitro to beta-cell lines, without changing cellular insulin content. Insulin secretion increased from 3 days of steroid exposure in vitro, suggesting that DHEAS did not directly activate the secretory processes. DHEAS selectively increased the beta-cell mRNA expression of acyl CoA synthetase-2 and peroxisomal acyl CoA oxidase in a time-dependent manner. Although DHEAS is a peroxisomal proliferator, it did not alter the mRNA expression of peroxisomal proliferator-activated receptor (PPAR) alpha or beta, or enhance the activity of transfected PPAR alpha, beta, or gamma in vitro. Thus, DHEAS directly affected the beta-cell to enhance glucose-stimulated insulin secretion and increased the mRNA expression of specific beta-cell mitochondrial and peroxisomal lipid metabolic enzymes. This effect of DHEAS on insulin secretion may contribute to the amelioration of hyperglycemia seen in various rodent models of diabetes.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008297 Male Males
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003066 Coenzyme A Ligases Enzymes that catalyze the formation of acyl-CoA derivatives. EC 6.2.1. Acyl CoA Synthetase,Acyl CoA Synthetases,Acyl Coenzyme A Synthetase,Acyl Coenzyme A Synthetases,Coenzyme A Ligase,Coenzyme A Synthetase,Coenzyme A Synthetases,Acid-Thiol Ligases,Co A Ligases,A Ligase, Coenzyme,A Synthetase, Coenzyme,Acid Thiol Ligases,CoA Synthetase, Acyl,CoA Synthetases, Acyl,Ligase, Coenzyme A,Ligases, Acid-Thiol,Ligases, Co A,Ligases, Coenzyme A,Synthetase, Acyl CoA,Synthetase, Coenzyme A,Synthetases, Acyl CoA,Synthetases, Coenzyme A
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J S Dillon, and G C Yaney, and Y Zhou, and N Voilley, and S Bowen, and S Chipkin, and C R Bliss, and V Schultz, and F C Schuit, and M Prentki, and D J Waxman, and B E Corkey
January 2005, The Journal of clinical investigation,
J S Dillon, and G C Yaney, and Y Zhou, and N Voilley, and S Bowen, and S Chipkin, and C R Bliss, and V Schultz, and F C Schuit, and M Prentki, and D J Waxman, and B E Corkey
October 1992, The Journal of biological chemistry,
J S Dillon, and G C Yaney, and Y Zhou, and N Voilley, and S Bowen, and S Chipkin, and C R Bliss, and V Schultz, and F C Schuit, and M Prentki, and D J Waxman, and B E Corkey
April 2024, International journal of molecular sciences,
J S Dillon, and G C Yaney, and Y Zhou, and N Voilley, and S Bowen, and S Chipkin, and C R Bliss, and V Schultz, and F C Schuit, and M Prentki, and D J Waxman, and B E Corkey
January 2006, FEBS letters,
J S Dillon, and G C Yaney, and Y Zhou, and N Voilley, and S Bowen, and S Chipkin, and C R Bliss, and V Schultz, and F C Schuit, and M Prentki, and D J Waxman, and B E Corkey
August 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
J S Dillon, and G C Yaney, and Y Zhou, and N Voilley, and S Bowen, and S Chipkin, and C R Bliss, and V Schultz, and F C Schuit, and M Prentki, and D J Waxman, and B E Corkey
June 2005, Seikagaku. The Journal of Japanese Biochemical Society,
J S Dillon, and G C Yaney, and Y Zhou, and N Voilley, and S Bowen, and S Chipkin, and C R Bliss, and V Schultz, and F C Schuit, and M Prentki, and D J Waxman, and B E Corkey
January 1994, Journees annuelles de diabetologie de l'Hotel-Dieu,
J S Dillon, and G C Yaney, and Y Zhou, and N Voilley, and S Bowen, and S Chipkin, and C R Bliss, and V Schultz, and F C Schuit, and M Prentki, and D J Waxman, and B E Corkey
October 2008, The Biochemical journal,
J S Dillon, and G C Yaney, and Y Zhou, and N Voilley, and S Bowen, and S Chipkin, and C R Bliss, and V Schultz, and F C Schuit, and M Prentki, and D J Waxman, and B E Corkey
June 2008, Biochemical Society transactions,
J S Dillon, and G C Yaney, and Y Zhou, and N Voilley, and S Bowen, and S Chipkin, and C R Bliss, and V Schultz, and F C Schuit, and M Prentki, and D J Waxman, and B E Corkey
April 1994, Endocrinology,
Copied contents to your clipboard!